MedPath

Erythromycin

Erythromycin Ophthalmic Ointment USP, 0.5% (Sterile)

Approved
Approval ID

37fcdb6e-2a9b-464f-9a0e-d3ca323fcb7a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 16, 2012

Manufacturers
FDA

H.J. Harkins Company, Inc.

DUNS: 147681894

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Erythromycin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52959-301
Application NumberANDA064067
Product Classification
M
Marketing Category
C73584
G
Generic Name
Erythromycin
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateFebruary 3, 2012
FDA Product Classification

INGREDIENTS (3)

ERYTHROMYCINActive
Quantity: 5 mg in 1 g
Code: 63937KV33D
Classification: ACTIB
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Erythromycin - FDA Drug Approval Details